Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Zinc-finger nucleases (ZFNs) are artificial restriction enzymes generated by fusing a zinc finger DNA-binding domain to a DNA-cleavage domain. Zinc finger domains can be engineered to target specific desired DNA sequences and this enables zinc-finger nucleases to target unique sequences within complex genomes. By taking advantage of endogenous DNA repair machinery, these reagents can be used to precisely alter the genomes of higher organisms. Alongside CRISPR/Cas9 and TALEN, ZFN is a prominent tool in the field of genome editing.
In 2018, the global Zinc Finger Nuclease Technology market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Zinc Finger Nuclease Technology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Zinc Finger Nuclease Technology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Sigma-Aldrich
Sangamo Therapeutics
Labomics
Thermo Fisher Scientific
Gilead
...
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Other
Biotechnology Companies
Pharmaceutical Companies
Hospital Laboratory and Diagnostic Laboratory
Academic and Research Institutes
Others
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
To analyze global Zinc Finger Nuclease Technology status, future forecast, growth opportunity, key market and key players.
To present the Zinc Finger Nuclease Technology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Zinc Finger Nuclease Technology are as follows:
History Year: 2014-2018
2018
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
In 2018, the global Zinc Finger Nuclease Technology market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Zinc Finger Nuclease Technology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Zinc Finger Nuclease Technology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Sigma-Aldrich
Sangamo Therapeutics
Labomics
Thermo Fisher Scientific
Gilead
...
Market segment by Type, the product can be split into
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Other
Market segment by Application, split into
Biotechnology Companies
Pharmaceutical Companies
Hospital Laboratory and Diagnostic Laboratory
Academic and Research Institutes
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Zinc Finger Nuclease Technology status, future forecast, growth opportunity, key market and key players.
To present the Zinc Finger Nuclease Technology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Zinc Finger Nuclease Technology are as follows:
History Year: 2014-2018
Base Year:
2018Estimated Year:
2019Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
